Enphase Energy Inc vs UnitedHealth Group Inc — how do they compare? Enphase Energy Inc trades at $32.81 (market cap $4.35B), while UnitedHealth Group Inc trades at $379.3 (market cap $332.96B). The key difference: UnitedHealth Group Inc is far larger — about 76.5× Enphase Energy Inc's market cap, and UnitedHealth Group Inc pays a 2.5% dividend while Enphase Energy Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Enphase Energy Inc for 72 Days and UnitedHealth Group Inc for 97 Days on average.
| ENPH | UNH | |
|---|---|---|
Market Cap | $4.35B | $332.96B |
Volume | 5,068,595 | 7,273,749 |
Sector | Energy | Health |
52-Week High | $72.33 | $436.35 |
52-Week Low | $26.12 | $259.02 |
Typical Hold Time | 72 Days | 97 Days |
Enterprise Value | $3.99B | $374.82B |
Dividend Yield | — | 2.5% |
Signals from Pluang's Aura AI — not financial advice
Enphase Energy (ENPH) trades at $32.91, down 1.76% amid bearish technical signals and mixed earnings performance. The stock faces headwinds from solar sector volatility but maintains solid fundamentals with 46.95% gross margins and positive cash flow. Recent developments include IQ Meter Collar utility approvals and solid-state transformer advancements for AI data centers, providing potential growth catalysts despite recent earnings misses.
The outlook remains cautious with analyst consensus at $42.90 offering 30% upside potential, though technical indicators suggest near-term pressure. Key risks include solar industry financing challenges and competitive threats, while institutional sentiment shows modest optimism with 42% buy ratings. The stock presents a growth opportunity for investors comfortable with sector volatility and execution risks.
UnitedHealth Group (UNH) trades at $370.95, down 1.34% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $6.38 versus $4.91 expected, and raised full-year guidance. Revenue for 2025 reached $447.57 billion, though net income margin declined to 2.69%. Analyst consensus remains strongly bullish with an 82.69% buy rating and a $470.11 price target, suggesting significant upside from current levels.
UNH presents a compelling investment case driven by earnings beats, raised 2026 outlook, and strategic initiatives like AI investment in Optum. Key risks include regulatory pressures in healthcare, volatility from Medicare Advantage plan changes, and margin compression. The stock's valuation at a P/E of 23.84 appears reasonable given growth prospects, but investors should weigh execution risks against the positive analyst sentiment and institutional backing.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
Read more on ENPH →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →